Medindia
Medindia LOGIN REGISTER
Advertisement

Agendia Appoints New Chief Financial Officer

Friday, January 9, 2009 General News
Advertisement
HUNTINGTON BEACH, California, and AMSTERDAM, January 8 Agendia, a world leader in molecular cancer diagnostics, today announced theappointment of Kurt Schmidt, CPA, MBA, as the company's new Chief FinancialOfficer.
Advertisement

"Kurt is an exceptional addition to our team and an invaluable asset,"said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With hisextensive financial management experience in the high tech and healthcareindustries, he will be instrumental in driving Agendia's next phase ofgrowth."
Advertisement

Mr. Schmidt succeeds former Chief Financial Officer, John de Die, who hasbeen an exemplary guide for Agendia during his tenure. Mr. Schmidt bringsmore than 25 years of financial, operational and entrepreneurial managementexperience, primarily in the high tech and healthcare industries in the U.S.and Europe. Most recently, he was a principal at a consulting firm he foundedin 2002, providing high-level interim financial management and M&A services.Prior to that, Mr. Schmidt served as Operations Director at B2eMarkets, asupply chain technology company, and Director of Finance & Operations at LAGear Europe. Mr. Schmidt started his career at Cardinal Health, Inc. incorporate finance.

"I am delighted to join Agendia during this exciting time and helpprepare the company for our next financing round. I look forward to our firstinvestor meetings next week during the JP Morgan Healthcare Conference in SanFrancisco," commented Kurt Schmidt, Chief Financial Officer.

About Agendia

Agendia is at the forefront of the personalized medicine revolution,striving to bring more effective, individualized treatments within reach ofpatients. Building on a cutting edge genomics platform for tumor geneexpression profiling, the company's tests aim to help physicians moreaccurately tailor cancer treatments. The company markets four products, withseveral new genomic tests under development. In addition, Agendiacollaborates with pharmaceutical companies to develop highly effectivepersonalized drugs in the area of oncology. Agendia was awarded the 2008North American Oncology Clinical Diagnostics Healthcare Innovation Award byFrost & Sullivan. Agendia is based in Huntington Beach, California, and inAmsterdam, The Netherlands. For more information please visithttp://www.agendia.com.

SOURCE Agendia B.V.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close